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To complete the amino acid sequence of GTPAMP phosphotransferase (MgGTP+AMP s 
MgGDP + ADP) from beef heart mitochondria it was necessary to sequence an intermediate region of about 
33 residues after position 102 [(1984) Eur. J. Biochem. 143, 331-3391 and find a suitable overlap with the 
rest of the protein. The required peptides were obtained by cleaving the enzyme with endoproteinase Lys-C. 
One peptide, covering the region from residue 79 to 144, was sequenced up to residue 124. Another peptide, 
extending from residue 79 to 169, was subcleaved with Staphylococcus aureus V8 protease and provided 
the fragment from residue 99 to 139 which was sequenced. Several other peptides from endoproteinase Lys- 
C cleavage were used to check large sections of the previously published sequence work. The complete se- 
quence contains 225 amino acids and has an M, of 25 469 
GTP:AMPphosphotransferase Mitochondria HPLC Amino acid sequence Gas-phase sequencer 
Adenylate kinase 
1. INTRODUCTION 2. MATERIALS AND METHODS 
GTP : AMP phosphotransferase (AK3, 
MgGTP + AMP = MgGDP + ADP) is an en- 
zyme homologous to adenylate kinase (ATP : AMP 
phosphotransferase) [ 1,2]. However, the two en- 
zymes differ with respect o their specificity for the 
nucleoside triphosphate. AK3 is specific for GTP 
(ITP) [3,4], while adenylate kinase uses ATP and, 
to some extent, other nucleoside triphosphates 
[5-71. Elucidation of the structures of these 
kinases is essential to solve their catalytic 
mechanism. The primary structures of several 
ATP : AMP phosphotransferases have been 
reported [8-131 and crystals from porcine AK1 
allowed the construction of a three-dimensional 
model at 0.3 nM resolution. Crystallographic 
studies on AK3 [14] as well as its partial primary 
structure [l] have been reported. The present work 
was undertaken to complete the amino acid se- 
quence of AK3 and thus facilitate further X-ray 
analyses. 
Endoproteinase Lys-C from Lysobacter en- 
zymogenes (Boehringer Mannheim) and 
Staphylococcus aureus VS protease (Miles 
Laboratories) were used for proteolytic cleavage. 
Reagents and solvents for the gas-phase sequencer 
were from Applied Biosystems. All other 
chemicals were of analytical grade. 
2.1. Protein preparation and proteolytic cleavages 
AK3 was prepared and assayed according to 
Tomasselli et al. [2]. The enzyme used here was 
homogeneous by SDS-polyacrylamide gel elec- 
trophoresis and had a specific activity of 
270-300 U/mg. 
2.2. Endoproteinase Lys-C cleavage, 
Two different procedures were used: (i) 
433 nmol AK3 was incubated with 56pg 
(12 U/mg) endoproteinase Lys-C in 3.6 ml of 
60 mM NH4HCO3, pH 8.2, at 37°C for 165 min. 
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Then, a further 4Opg endoproteinase Lys-C was 
added to the incubation mixture and the digestion 
continued for another 165 min. lOO$ incubation 
mixture was withdrawn, boiled for 10 min, dried, 
taken up with 60% acetonitrile in 0.1% TFA (solu- 
tion B) and analyzed by HPLC. Since the pro- 
teolytic cleavage was poor, the main incubation 
mixture was made 0.1% in SDS and allowed to 
react for another 15 h. The reaction was stopped 
by boiling for 10 min. It was dried and taken up 
with solution B for HPLC separation. (ii) 
100 nmol AK3 in 1 .O ml of 60 mM NHdHCOs, pH 
8.2, was warmed to 60°C for 15 min to unfold the 
protein. It was then incubated with 42 pg endopro- 
teinase Lys-C at 37°C for 165 min. 21 pg endopro- 
teinase Lys-C was added to the incubation mixture 
and the reaction continued for another 135 min. 
The products were analyzed by HPLC. 
2.3. S. aureus V8 protease cleavage 
S. aureus V8 protease [ 151 sub-digestion of K15 
(fig.1) was carried out with 15 nmol peptide and 
30 pg protease in 300 ~1 of 60 mM NH4HCO3, pH 
7.5-8.0, at 37°C for 25 h. The reaction was 
stopped by boiling for 15 min and the products 
analyzed by HPLC. 
2.4. /Sequence analysis 
Amino acid analysis with l-5 nmol peptide, Ed- 
man degradation with 0.5-5 nmol peptide, and 
identification of the amino acid-phenylthiohydan- 
toins were done as described in [12]. Here, a gas- 
phase sequencer (model 47OA, Applied Biosys- 
I 
terns) was used. The initial and repetitive yields 
were 48 + 22 and 93 + 5%, respectively. An amino 
acid-phenylthiohydantoin was accepted when the 
area corresponding to its peak increased more than 
40% over its value in the preceding cycle. Each 
residue in the missing area was sequenced at least 
twice in different peptides. 
3. RESULTS AND DISCUSSION 
The sequence of AK3 was previously published 
with a gap of about 33 residues after residue 102 
[l]. Fig. 1 summarizes the strategy we have used 
here to fill the gap and to check large sections of 
the previously published sequence work. AK3 was 
cleaved with endoproteinase Lys-C using pro- 
cedures (i) and (ii). The peptides resulting from 
these cleavages were separated by HPLC (fig.2a,b) 
and analyzed for amino acid compositions. Both 
K15 and K16 contained the unsequenced segment. 
Their amino acid compositions and HPLC yields 
and those of K’ 14 and of subcleavage products of 
K15 (see below) are given in table 1. Those peptides 
shown in fig.1 but not presented in table 1 had 
amino acid compositions that confirmed the 
previously published sequence. 
K15, covering the region from residue 79 to 169, 
was subcleaved with S. aureus VS protease. After 
drying, the products of the cleavage were taken up 
with 0.1% TFA (solution A of the HPLC), cen- 
trifuged, and the supernatant analyzed by HPLC 
(fig.2c). Amino acid compositions (table 1) of the 
well-resolved peptides of fig.2c indicated that the 
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Fig. 1. Summary of the proof of the GTP : AMP phosphotransferase (AK3) sequence. The nomenclature of the peptides 
is explained in fig.2 except for K’ ’ 18, a peptide obtained from subcleavage of a cyanogen bromide fragment (called 
C2C5 in [ 11) with endoproteinase Lys-C. The peptides underlined by > were sequenced by Edman degradation, except 
for the residues underlined by l which were only identified by amino acid analysis. 
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Table 1 
Amino acid compositions of endoproteinase Lys-C peptides (K...) and S. aureus V8 subcleavage 
products (KISE...) 
K’14 K16 K15 K15Ell/ K15E6 K15E’3 K15E9 K15E4 K15E3 
121-144 79-144 79-169 E’2 89-98 99-139 140-160 161-165 166-169 
79-88 
Asx 1.7 (2) 8.6 (9) 12.2 (13) 2.7 (3) - 5.0 (5) 3.0 (3) 1.8 (2) - 
Thr 0.9 (1) 3.9 (4) 6.8 ( 7) 1.1 (1) 0.7 (1) 2.0 (2) 2.1 (2) - 1.0 (1) 
Ser 1.2 (1) 1.2 (1) 1.3 ( 1) - - 1.1 (I) - - - 
Glx 1.7 (2) 7.3 (7) 11.1 (11) 1.0 (1) 2.2 (2) 4.3 (4) 3.3 (3) 1.1 (1) - 
Pro 2.8 (3) 5.7 (6) 7.7 ( 8) - 2.1 (2) 2.1 (2) 2.8 (3) 1.0 (1) - 
CJY 1.8 (2) 3.0 (3) 4.8 ( 5) - 1.1 (1) 2.1 (2) 2.0 (2) - - 
Ala 1.0 (1) 4.0 (4) 3.9 ( 4) - 1.1 (1) 2.3 (3) - _ - 
Val 0.5 (1) 1.5 (4) 2.7 ( 7) - - 2.0 (2) 0.6 (1) - 1.3 (2) 
Met - - 0.9 ( 1) - _ - 0.8 (1) - _ 
Be 1.1 (2) 2.3 (5) 3.4 ( 6) - - 2.8 (5) 0.8 (1) - - 
Leu 1.3 (1) 7.3 (7) 9.1 ( 9) 3.0 (3) 0.7 (1) 3.0 (3) 2.1 (2) - - 
Tyr 0.8 (1) 2.7 (3) 3.1 ( 3) 1.0 (1) - 1.7 (2) - - - 
Phe 1.0 (1) 3.2 (3) 3.4 ( 3) - 0.9 (1) 1.0 (1) 1.1 (1) - - 
LYS 1.3 (1) 2.0 (2) 2.9 ( 3) - - 1.0 (1) 1.2 (1) - 1.2 (1) 
His 0.8 (1) 0.8 (1) 0.8 ( 1) - - 0.5 (1) - - - 
Arg 2.6 (3) 4.5 (5) 6.6 ( 7) - 1.1 (1) 4.0 (4) 1.8 (2) 1.1 (1) - 
Trp -a (1) -a (2) -= ( 2) - (1) - - (1) - - - 
Total 24 66 93 10 10 39 22 5 4 
yield ((TJo) 27 17 18 54 75 30 51 78 61 
a Tryptophan was found by Ehrlich reagent 
Amino acids found in the sequence are in parentheses. (-) Values lower than 0.3 
sequence spanning from residue 99 to 139 was 
missing. Hence, we dissolved the precipitate in 
solution B (of the HPLC) and analyzed it by the 
same HPLC procedure (fig.2d). Peptide K15E’3 
was sequenced and it covered the region from 
residue 99 to 139 producing the needed overlap. 
Peptide K15E ’ 2 had the same amino acid composi- 
tion as peptide K15Ell (fig.2c). K’ 14 strengthened 
the overlap in the area under study, identified 
positively Arg 134 (that was unclear in the KlSE’ 3 
sequence) and confirmed the K15E’ 3 sequence. 
The sequence of K16 revealed that a Trp in posi- 
tion 85 and not a Pro as previously published [l] 
was present. Furthermore, the sequence of K15E’3 
could not confirm the sequence of a peptide called 
T16 in [l]. T16, that was provisionally assigned to 
the gap region [l], had the positions of Trp and 
Pro reversed and contained an additional Thr 
residue poorly supported by amino acid composi- 
tion. The problem concerning Trp and Pro was 
caused by the difficulty in separating phenylthio- 
hydantoin-Trp and phenylthiohydantoin-Pro with 
the HPLC column and the conditions used in [l]. 
All other Trp and Pro residues published in [I] 
were checked (fig.1) and found to be correct. 
Concerning the specificity of Lys-C we have 
noted that, when AK3 was denatured with SDS, 
there was no appreciable cleavage at several Lys. 
For example, both the peptides K16 and K15 (ob- 
tained with 17 and 18% yield, respectively) con- 
tained Lys 120, and peptide K9 (173-225) (obtain- 
ed with 38% yield) contained 4 Lys. On the other 
hand, when AK3 was denatured by heat, the 
cleavage at Lys 120 took place (recovery of peptide 
K’14 was 27%) and instead of K9 we obtained 4 
fragments as a result of cleavage at Lys 188, 201 
and 213 (Lys 187 was not cleaved). 
Concerning the specificity of the S. aureus V8 
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Fig.2. Separations of peptides by reverse-phase HPLC. (a,b) Cleavage of AK3 with endoproteinase Lys-C: (a) in the 
presence of SDS (peptides named K.. .), (b) in the absence of SDS (peptides named K’ . . .). (c,d) Subcleavage of K15 
with S. aureus V8 protease: (c) the samples were taken up in 0.1% TFA (solution A), centrifuged and the supernatant 
injected (peptides named KlSE.. .), (d) the pellet of the centrifugation was taken up with 60% acetonitrile in 0.1% TFA 
(solution B) and injected (peptides named KJSE’ . . . ). Each set of peptides was numbered according to elution from 
the HPLC. In all cases a gradient of O-100% solution B vs 0.1% TFA was run through a pBondapak phenyl column 
(Waters) at a flow rate of 1.0 ml/min at 50°C. (a,b) 80 min gradient; (c,d) 60 min gradient. Amounts of samples 
injected: (a) 4.5 nmol, (b) 5.5 nmol, (c) 3.4 nmol, (d) 3.2 nmol. A DuPont 830 liquid chromatograph equipped with 
an 838 programmable gradient was used. 
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protease, we have noted that ‘among the 7 Asp 
residues present in peptide Kl5 only the Asp-Gly 
linkage was cleaved at an appreciable rate, in 
agreement with [15]. Among the 6 Glu residues 
present he Glu-Vai bond was resistant o cleavage 
as reported in [ 151. We have also noted that the 
Glu-Pro bond was resistant o cleavage, while the 
Glu-Phe bond was split even though the recovery 
of that peptide was somewhat lower than for the 
other E peptides (table 1). 
In the present work the N-terminus of AK3 was 
also found to be heterogeneous as reported [ 11. We 
are confident that the sequence segments of a total 
of 44 amino acids not checked in the present work 
are correct, since it was obtained at least 3 times 
from different peptides in [l]. 
The complete sequence analysis shows that AK3 
has 225 amino acids (I@ 25469). This 1%4, was used 
to recalculate the enzyme’s amino acid composi- 
Table 2 
Amino acid composition of GTP : AMP 
phosphotransferase 
tion from the data of [2]. The amino acid composi- 
tion calculated here (table 2) is in good agreement 
with that inferred from the sequence analysis. In 
[l] the N-terminal residues l- 102 and the C- 
terminal residues 135-225 (final numbering) of 
AK3 were aligned to the sequence of AKI. The 
complete sequence of AK3 confirms the correct- 
ness of the alignment. AK3 has 31 amino acids 
more than AK1 [S] and 13 less than AK2 [l I]. Both 
AK3 and AK2 have a stretch of amino acids (25 in 
AK3, 30 in AK2) in the middle of the chain that is 
also present in cytosolic AK from yeast [ 121 and E. 
coli [ 131, but absent in mammalian cytosolic AK1 
[8-lo]. The function of this additional sequence 
will be clarified when the forthcoming X-ray 
analysis yields the tertiary structure of the enzyme. 
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A B 
Aspartic acid and 
asparagine 
Threonine 
Serine 
Glutamic acid and 
glutamine 
Proline 14.2 
Cilycine 15.4 
Atanine 13.4 
Valine 14.3 
Methionine 3.6 
Isoleucine 11.3 
Leucine 27.2 
Tyrosine 7.0 
PhenylaIanine 6.9 
Histidine 4.6 
Lysine 14.0 
Arginine 15.9 
Tryptophan 2.0 
TotaI residues 
20.2 
18.6 
11.6 
25.1 
(12 Asp?8 Asn) 
19 
10 
25 
(15 Glu + 10 Gln) 
14 
16 
12 
I5 
4 
12 
26 
7 
7 
5 
14 
16 
3 
225 
(A) Calculated from the data of [2] assuming Iw, 25469; 
(B) from sequence data 
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